HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Altered peptide ligands can modify the Th2 T cell response to the immunodominant 161-175 peptide of LACK (Leishmania homolog for the receptor of activated C kinase).

Abstract
Following Leishmania major infection, the early LACK (Leishmania homolog of receptors for activated C kinase)-induced IL-4 response appears to determine disease susceptibility in BALB/c mice. Therefore, we sought to manipulate the pathogenic T cell responses to the immunodominant epitope with the use of altered peptide ligands (APLs). Conservative and non-conservative substitutions for each amino acid of the LACK 161-175 peptide determinant were tested for their stimulatory capacity in four different LACK-reactive T cell systems. From these results, we propose a likely LACK 163-171/I-A(d) core peptide register and show that APLs with changes at putative T cell receptor (TCR) contacts provide the greatest potential for immune deviation. In particular, the TCR-contact H164V APL expanded Th1 cells upon in vitro recall of naïve splenocytes from LACK-specific BV4 T cell receptor transgenic mice and stimulated IFN-gamma secretion from a Th2-committed LACK-reactive T cell line. We also observed that non-conservative substitutions flanking the core determinant had strong agonistic effects for proliferation and Th1/Th2 modulation. However, upon immunization, the H164V APL considerably downregulated proliferation and cytokine responses to the wild type LACK 161-175 peptide, while immunization with the weak agonist, MHC contact APL S171K, increased the IFN-gamma/IL-4 ratio to the wild type peptide. In these instances, a hyporesponsive T cell response to the wild-type peptide was achieved by immunizing with an APL possessing non-conservative substitutions at TCR contact sites, while immune deviation was accomplished using a weak-agonist APL that retained the core determinant. Thus, certain LACK-APLs are able to induce T cell responses with a protective phenotype in an infectious disease such as leishmaniasis.
AuthorsKirk D C Jensen, Eli E Sercarz, Claudia Raja Gabaglia
JournalMolecular immunology (Mol Immunol) Vol. 46 Issue 3 Pg. 366-74 (Jan 2009) ISSN: 0161-5890 [Print] England
PMID19042022 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Antigens, Protozoan
  • Cytokines
  • Immunodominant Epitopes
  • Ligands
  • Peptides
  • Protozoan Proteins
  • Protozoan Vaccines
  • Receptors, Antigen, T-Cell
  • LACK antigen, Leishmania
  • Interleukin-4
  • Interferon-gamma
Topics
  • Amino Acid Sequence
  • Amino Acid Substitution
  • Animals
  • Antigens, Protozoan (chemistry, immunology)
  • Cell Line
  • Cell Proliferation
  • Cross-Priming (immunology)
  • Cytokines
  • Immunization
  • Immunodominant Epitopes (immunology)
  • Interferon-gamma (immunology)
  • Interleukin-4 (immunology)
  • Leishmania major (immunology)
  • Ligands
  • Mice
  • Mice, Inbred BALB C
  • Mice, Transgenic
  • Molecular Sequence Data
  • Peptides (chemistry, immunology)
  • Protozoan Proteins (chemistry, immunology)
  • Protozoan Vaccines (immunology)
  • Receptors, Antigen, T-Cell (immunology)
  • Th2 Cells (cytology, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: